Assignee
UMECRINE AB
SE·3 granted patents·4 pending applications·1 citations·filing 2002–2022
Top patents by PatentIndex Score
7 records- 0170US8853190B2Steroids having increased water solubility and resistance against metabolism, and methods for their productionUMECRINE AB·Filed 2013·Granted Oct 7, 2014·1 cites·2 claims
- 0257US2024383941A13-alpha substituted 3-beta-hydroxy-17-oximated androstane compound for modulation of the alpha-3 subtype of the gabaa receptorUMECRINE AB·Filed 2022·Application pending·0 cites
- 0356US2013102579A1Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their ProductionUMECRINE AB·Filed 2012·Application pending·0 cites
- 0456US2013102578A1New Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their ProductionUMECRINE AB·Filed 2012·Application pending·0 cites
- 0553US2015315231A1New Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their ProductionUMECRINE AB·Filed 2015·Application pending·0 cites
- 0645US8372824B2GABA-steroid antagonists and their use for the treatment of CNS disordersUMECRINE AB·Filed 2012·Granted Feb 12, 2013·0 cites·6 claims
- 0745US7960367B2Pregnane steroids and their use in the treatment of CNS disordersUMECRINE AB·Filed 2002·Granted Jun 14, 2011·0 cites·19 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →